High US drug prices have global implications

BMJ

22 March 2022 - Lower income countries need better protection from an unfettered US market.

This is a critical time for pharmaceutical reform in the United States. The Biden administration introduced the Build Back Better Bill, which included several provisions to reduce prescription drug costs.

Read BMJ Editorial

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Pricing , Health policy